Megs Pharmaceutical Limited

Megs Pharmaceutical Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
CIN U74999RJ2017PLC058722 Incorporated 03 August 2017 ROC Jaipur HQ Jaipur, Rajasthan, India
Active Public Limited Company pharma MSME · Micro
Revenue · FY 2024
₹1.51 Cr
▲ 51% YoY
Net profit · FY 2024
₹6,953
Net margin 0%
EBITDA · FY 2024
₹3.2 Lakh
EBITDA margin 2.1%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Open charges
₹38 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings

About Megs Pharmaceutical Limited

Data last updated:

Megs Pharmaceutical Limited is a public limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 August 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2017PLC058722. Its GSTIN is 08AALCM2432Q1ZY (Rajasthan).

The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Vrishdev Singh (Whole-Time Director) and Vijendra Singh Rathore.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No.D – 82 Flat No.S – 1 2nd Floor Manglam City Vill – Hathoj, Jaipur, Rajasthan, India – 302012.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.51 Cr, a growth of 51% compared to the previous year. For the same year it recorded a net profit of ₹6,953 (net margin 0%) and EBITDA of ₹3.2 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years and 101% over five years.

As per MCA filings, the company has open charges of ₹38 Lakh on record.

Megs Pharmaceutical Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0157297). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999RJ2017PLC058722
Registration Number 058722
Incorporation Date 03 August 2017
ROC Jaipur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0157297

Recognitions & Rankings of Megs Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-RJ-17-0157297

Contact details

Megs Pharmaceutical Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.

  • Email
  • Registered Address
    P.No.D – 82 Flat No.S – 1 2nd Floor Manglam City Vill – Hathoj, Jaipur, Rajasthan, India – 302012
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Megs Pharmaceutical Limited, buy the company report.

Comprehensive company report
Megs Pharmaceutical Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Megs Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Megs Pharmaceutical Limited, buy the company report.

Financials of Megs Pharmaceutical Limited

FY 2025 filings available

Megs Pharmaceutical Limited reported revenue of ₹1.51 Cr (up 51% YoY) for FY 2024.

Revenue · FY 2024
₹1.51 Cr ▲ 51%
Net profit · FY 2024
₹6,953 margin 0%
EBITDA · FY 2024
₹3.2 Lakh margin 2.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 51%
3 years · compounded
▲ 81%
5 years · compounded
▲ 101%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 39%
5 years · compounded
▲ 114%

Revenue has grown at a compounded annual rate (CAGR) of 101% over five years, including 51% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.2 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6,953
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin2.1%
Net Profit Margin0%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Megs Pharmaceutical Limited, buy the company report.

Board of directors of Megs Pharmaceutical Limited

Megs Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vijendra Singh RathoreDirector26 Jan 20206 Years 9 MonthsCurrent
Ray SinghDirector03 Aug 20179 Years 3 MonthsCurrent
Vrishdev SinghWhole-Time Director03 Aug 20179 Years 3 MonthsCurrent

Peer comparison

Megs Pharmaceutical Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
C-Squared Pharma India Private Limited₹1.51 Cr (FY 2025)56.0%Mumbai, Maharashtra, India
Alcuria Pharma Private Limited₹1.51 Cr (FY 2025)21.0%Greater Noida, Uttar Pradesh, India
Chandramouli Industries Private Limited₹1.51 Cr (FY 2024)-35.0%Dhamdha, Chhattisgarh, India
Welora Lifesciences Private Limited₹1.51 Cr (FY 2019)842.0%Chandigarh, India
Shree Baidyaraj Ayurved Bhawan Private Limited₹1.51 Cr (FY 2025)11.0%New Delhi, Delhi, India
Megs Pharmaceutical Limitedthis company₹1.51 Cr (FY 2024)₹6,9530%51.0%Jaipur, Rajasthan, India
Perduro (OPC) Private Limited₹1.5 Cr (FY 2023)-85.0%Chandigarh, India
Harishree Aromatics and Chemicals Private Limited₹1.5 Cr (FY 2022)-28.0%Mumbai, Maharashtra, India
Lenore Pharmaceuticals Private Limited₹1.5 Cr (FY 2024)31.0%Lucknow, Uttar Pradesh, India
Medvina Healthcare Private Limited₹1.5 Cr (FY 2025)15.0%Dehradun, Uttarakhand, India
Destiny Hi-Tech Medicines Private Limited₹1.5 Cr (FY 2021)13.0%Kota, Rajasthan, India

To see the full peer comparison of Megs Pharmaceutical Limited, buy the company report.

Charges & borrowings

Open charges
₹38 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.38 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
16 Dec 2023100889910Others₹25 LakhOpen
31 Jan 2022100538203Others₹2 LakhOpen
01 Sep 2021100476310Others₹10 LakhOpen
01 Sep 2021100479818Others₹1 LakhOpen

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Megs Pharmaceutical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Megs Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AALCM2432Q1ZYRajasthanActive25 Jul 2018

To see the full GST registrations and return filing status of Megs Pharmaceutical Limited, buy the company report.

Recent activity

Megs Pharmaceutical Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Santosh Singh ceased to be Whole-Time Director on 29 Jan 2020.

AGM
Megs Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Megs Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100889910 was registered on 16 Dec 2023.
Charges
A charge with Others amounted to Rs. 2.00 Lakh with Charge ID 100538203 was registered on 31 Jan 2022.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100476310 was registered on 01 Sep 2021.
Charges
A charge with Others amounted to Rs. 1.00 Lakh with Charge ID 100479818 was registered on 01 Sep 2021.
Ceased
Santosh Singh ceased to be Whole-Time Director.
Appointed
Vijendra Singh Rathore was appointed as Director.
Ceased
Pushpendra Singh Shekhawat ceased to be Managing Director.
Appointed
Ray Singh was appointed as Director.
Appointed
Vrishdev Singh was appointed as Whole-Time Director.
Incorporation
03 Aug 2017
Megs Pharmaceutical Limited was registered on 03 Aug 2017 with Roc Jaipur & aged 9 years 3 months as per MCA records.

Frequently asked questions

Megs Pharmaceutical is an active public limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 August 2017 (9+ years old) and is registered under CIN U74999RJ2017PLC058722.

Megs Pharmaceutical has 3 current directors:

The latest financial statements of Megs Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Megs Pharmaceutical is 08AALCM2432Q1ZY, registered in Rajasthan.

The CIN (Corporate Identification Number) of Megs Pharmaceutical is U74999RJ2017PLC058722. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Megs Pharmaceutical was incorporated on 03 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Megs Pharmaceutical by revenue are C-Squared Pharma India Private Limited, Alcuria Pharma Private Limited, Chandramouli Industries Private Limited, Welora Lifesciences Private Limited, Shree Baidyaraj Ayurved Bhawan Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Santosh Singh ceased to be Whole-Time Director on 29 Jan 2020. Vijendra Singh Rathore was appointed as Director on 26 Jan 2020. Pushpendra Singh Shekhawat ceased to be Managing Director on 04 Oct 2019. Megs Pharmaceutical has 5 board changes on record in total.

Yes, Megs Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0157297).

The registered office of Megs Pharmaceutical is at P.No.D – 82 Flat No.S – 1 2nd Floor Manglam City Vill – Hathoj, Jaipur, Rajasthan, India – 302012.

Megs Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.